David Brian Olsen

USPTO Granted Patents = 37 (Patent Applications = 16)

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 48 (Patent Applications = 52)

Average Co-Inventor Count = 6.2

ph-index = 17

Forward Citations = 1,490(Granted Patents)

Location History:

Rahway, NJ (US) (2002)
West Point, PA (US) (1997 - 2005)
Landsdale, PA (US) (2018)
Lansdale, PA (US) (1997 - 2023)

Company Filing History:

19 out of 2,405

Merck Sharp + Dohme Corp.

Isis Pharmaceuticals, Inc.

patents

4. 4 out of 1,288

Max-planck-gesellschaft Zur Forderung Der Wissenschaften E.v.

patents

5. 3 out of 80

The Walter and Eliza Hall Institute of Medical Research

patents

6. 2 out of 10

Msd R&d (china) Co., Ltd.

patents

7. 1 out of 47

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

patents

8. 1 out of 1

Merch Sharpe & Dohme LLC

patent

9. 1 out of 3

Merck Sharp & Dohme De Espana Sa

patents

10. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

37 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12459933 - Compounds and methods of use thereof as antibacterial agents (2025-11-04),

2. 12435077 - Oxazolidinone compound and methods of use thereof as an antibacterial agent (2025-10-07),

3. 12365656 - Oxazolidinone compounds and methods of use thereof as antibacterial agents (2025-07-22),

4. 12350270 - Antimalarial agents (2025-07-08),

5. 12338219 - Antimalarial agents (2025-06-24),

6. 11766435 - N3-substituted iminopyrimidinones as antimalarial agents (2023-09-26),

7. 10947205 - Oxazolidinone compounds and methods of use thereof as antibacterial agents (2021-03-16),

8. 10144741 - Nargenicin compounds and uses thereof as antibacterial agents (2018-12-04),

9. 9944654 - Nargenicin compounds and uses thereof as antibacterial agents (2018-04-17),

10. 9777035 - 4'-substituted nucleoside reverse transcriptase inhibitors (2017-10-03),

11. 9765107 - Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2017-09-19),

12. 9416154 - 5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2016-08-16),

13. 9156872 - 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2015-10-13),

14. 9150603 - 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases (2015-10-06),

15. 9126983 - Extracts from kibdelos porangium as antibacterial agents (2015-09-08),

Title: The Innovative Journey of David Brian Olsen

Introduction: David Brian Olsen, a talented inventor hailing from Lansdale, PA (US), has made significant contributions to the field of innovations with his creative mindset and dedication.

Latest Patents: David Brian Olsen's latest patents showcase his commitment to pushing the boundaries of technology and design, with a focus on improving everyday life through his inventions.

Career Highlights: Throughout his illustrious career, David Brian Olsen has demonstrated a keen eye for identifying gaps in the market and developing groundbreaking solutions. His innovative spirit has led to the creation of several patented inventions that have garnered attention in the industry.

Collaborations: David Brian Olsen's collaborative efforts with fellow inventors, patent attorneys, and research institutions have been instrumental in bringing his ideas to life. By working closely with experts in various fields, he has been able to refine his inventions and ensure their success in the market.

Conclusion: In conclusion, David Brian Olsen's journey as an inventor is a testament to his passion for innovation and his unwavering commitment to making a positive impact on the world. His contributions to the field continue to inspire aspiring inventors and pave the way for future advancements in technology.

This text is generated by artificial intelligence and may not be accurate.